High materiality7/10
Vir Biotechnology price target raised to $22 from $20 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
VIR target updated; H.C. Wainwright raises price target to $22 from $20, suggesting upside versus the current price.
- Target raised to $22 from $20 by H.C. Wainwright
Key facts
- 01
Target: $22
- 02
Posted price: $11.68
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Patrick Trucchio
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.